血液内科研究業績
2025年
1.学会発表等
| 1-1 | Yusuke Okayama : Complement involvements and issues in TA-TMA after allogeneic hematopoietic cell transplantation, 第47回日本造血・免疫細胞療法学会総会, 2025.02.27-03.01 |
| 1-2 | 細井悠介, 高桑輝人, 岡山裕介, 福山智子 : EDTA 非依存性血小板凝集においてEDTA 過剰添加採血管が有用である可能性, 第74回日本医学検査学会, 2025.05.10-11 |
| 1-3 | 髙桑輝人 : 関西骨髄腫フォーラム（KMF）13年の軌跡, 第50回日本骨髄腫学会学術集会, 2025.05.23-25 |
| 1-4 | 髙桑輝人 ,堀田 雅章 , 藤田 真也, 志村 勇司, 花本 仁, 吉原 哲, 芹澤 憲太郎, 淵田 真一, 松本 忠彦, 諫田 淳也, 河田 英里, 一井 倫子, 福島 健太郎, 伊藤 量基, 黒田 純也, 松村 到, 島崎 千尋, 高折 晃史, 日野 雅之, 保仙 直毅 : NDMMの腎機能と予後への寄与度 -関西骨髄腫フォーラム後方視的研究-, 第50回日本骨髄腫学会学術集会, 2025.05.23-25 |
| 1-5 | Tomoaki Fujisaki , Kohmei Kubo, Yasushi Hiramatsu, Ryosuke Ogawa, Shinsuke Iida, Takashi Ikeda, Hiromi Iwasaki, Shingo Kurahashi, Morio Matsumoto, Tomonori Nakazato, Kazutaka Sunami, Teruhito Takakuwa, Yotaro Tamai, Kazuki Tanimoto, Junichi Tsukada, Ryosuke Yamamura, Taku Fujii, Akira Endo, Hirofumi Nakano, Joe Lee : Belantamab mafodotin, bortezomib, dexamethasone for RRMM: the DREAMM-7 Japanese expansion cohort, 第50回日本骨髄腫学会学術集会, 2025.05.23-25 |
| 1-6 | 岡山裕介 ,谷澤直, 相本瑞樹, 平井学, 太田健介, 髙桑輝人 : 当院における再発難治多発性骨髄腫に対するelranatamabの使用経験, 第50回日本骨髄腫学会学術集会, 2025.05.23-25 |
| 1-7 | Hang Quach , Bradley Augustson, Linda Barton, Edvan de Queiroz Crusoe, Jeffrey S.Y. Huang, Vania Hungria, Marek Hus, Karthik Ramasamy, Teruhito Takakuwa, Dok Hyun Yoon, Rupam Pal, Shreyan Banerjee, Hari Narayan, Wei Sun, Malika Ahras, Seema Shafi-Harji, Sarantos Kaptanis, Giulia Fulci, Brandon Kremer, and Chang-Ki Min : Belantamab treatment of multiple myeloma: Results from part 1 of the first-in-human phase 1/2 DREAMM-20 trial, ASCO(American Society of Clinical Oncology) Annual Meeting, 2025.05.30-06.03 |
| 1-8 | Hang Quach , Bradley Augustson, Linda Barton, Edvan Crusoe, Jeffrey Huang, Vania Hungria, Marek Hus, Karthik Ramasamy, Teruhito Takakuwa, Dok Hyun Yoon, Elisabet Manasanch, John Clements, Xiangdong Zhou, Rupam Pal, Shreyan Banerjee, Hari Narayan, Wei Sun, Malika Ahras, Seema Shafi-harji, Sarantos Kaptanis, Giulia Fulci, Brandon E. Kremer, Chang-Ki Mi :BELANTAMAB FOR THE TREATMENT OF MULTIPLE MYELOMA: RESULTS FROM PART 1 OF THE FIRST-IN-HUMAN PHASE 1/2 DREAMM-20 TRIAL, 30th EHA(European Hematology Association) Congress, 2025.06.12-15 |
| 1-9 | 熊谷綾太, 玉村悠介, 松浦道子, 朝川弘章, 岡山裕介, 髙桑輝人 : 造血器腫瘍患者のシームレスなリハビリテーション提供体制の構築に向けた法人内施設間連携, 第75回日本病院学会, 2025.07.24-25 |
| 1-10 | 細井悠介, 岡山裕介、福山智子、高桑輝人 : 芽球に幼若赤芽球抗原を発現した骨髄異形成関連変化を伴う急性骨髄性白血病（AML-MR）の一例, 第26回日本検査血液学会学術集会, 2025.07.26-27 |
| 1-11 | 日野 雅之, : 同種造血幹細胞移植の進化と将来展望, 第33回日本組織適合性学会大会, 2025.10.03-05 |
| 1-12 | Kentaro Serizawa, Masaaki Hotta, Shinya Fujita, Yuji Shimura, Tadahiko Matsumoto, Junya Kanda, Satoshi Yoshihara, Shin-ichi Fuchida, Eri Kawata, Hitoshi Hanamoto, Michiko Ichii, Kentaro Fukushima, Yosuke Nakaya, Teruhito Takakuwa, Tomoki Ito, Junya Kuroda, Akifumi Takaori-Kondo, Chihiro Shimazaki, Masayuki Hino, Itaru Matsumura, Naoki Hosen :Real-world efficacy of isatuximab, carfilzomib, and dexamethasone in RRMM: KMF database analysis, 第87回日本血液学会学術集会, 2025.10.10-12 |
| 1-13 | Takahiro Sunano, Yusuke Okayama, Yusuke Tanada, Masayuki Hino, Teruhito Takakuwa :Real-world efficacy of isatuximab, carfilzomib, and dexamethasone in RRMM: An autopsy case of CPX-351-resistant AML-MR with immature erythroid antigen positivity, 第87回日本血液学会学術集会, 2025.10.10-12 |
| 1-14 | Yusuke Tanada, Yusuke Okayama, Masayuki Hino, Teruhito Takakuwa :Colitis as an immune-related adverse event of elranatamab in a refractory plasma cell leukemia, 第87回日本血液学会学術集会, 2025.10.10-12 |
| 1-15 | 加藤真由美, 今堀友紀, 棚田悠介, 岡山裕介, 山中英治, 日野雅之, 髙桑輝人 :造血器腫瘍領域の化学療法を担う薬剤師によるパス作成と運用評価, 第25回日本クリニカルパス学会, 2025.10.17-18 |
| 1-16 | 髙桑輝人, 多田雄真, 中舎洋輔, 太田健介, 小曽根南美, 山本薫, 中前博久, 日野雅之, 横田貴史 :造血器腫瘍における地域医療連携プラットフォームの構築と活用, 第25回日本リハビリテーション医学会秋季学術集会, 2025.10.17-18 |
| 1-17 | 熊谷綾太, 玉村悠介, 米谷正樹, 髙桑輝人 :血液腫瘍患者における退院時ADLと身体および呼吸機能との関連, 第9回日本クリニカルパス学会, 2025.10.23-25 |
2024年
1.学会発表等
| 1-1 | 高桑輝人,岡山裕介,山中英治: 「血液連携パス」を活用した拠点病院と地域医療との橋渡し, 第24回日本クリニカルパス学会学術集会, 愛媛, 2024.10.04-05(一般口演) |
| 1-2 | 加藤 真由美,中田 敦子, 平櫛 実穂, 上田 展代, 野口 智恵子, 山本 直美, 今田 光一, 山中 英治, 岡山 裕介, 高桑 輝人:電子カルテベンダー変更と電子パス導入における薬剤師の関わり , 第24回日本クリニカルパス学会学術集会, 2024.10.04-05 |
| 1-3 | Mitsuhiro Itagaki , Tomoaki Fujisaki, Yoshiaki Ogawa, Teruhito Takakuwa, Anna Sureda Balari, Abdullah Mohammad Khan, Albert Oriol, Mercedes Gironella Mesa, Faiz Anwer, Cristina Encinas Rodríguez, Brea Lipe, Paula Rodríguez Otero, Jie Pu, Michael Amatangelo, Kexin Jin, Sakiko Kuroda, Thomas Solomon, Lilia Taningco, Alpesh Amin, Paulo Maciag, Sagar Lonia :Iberdomide, daratumumab, and dexamethasone (IberDd) in newly diagnosed multiple myeloma (NDMM) , 第86回日本血液学会学術集会, 京都, 2024.10.11-13(一般口演) |
| 1-4 | Teruhito Takakuwa, Ikue Shiki, Ryosuke Yamamura, Kensuke Ohta, Naoko Yagi, Naonori Harada, Masafumi Fukaya, Kanako Yoshitsugu, Hiroshi Okamura, Taku Araki, Yotaro Fujitani, Mitsutaka Nishimoto, Terukazu Enami, Yasuhiro Nakashima, Takahiko Nakane, Mika Nakamae, Hirohisa Nakamae, Atsuko Mugitani, Takafumi Nakao, Takashi Ikeda, Masayuki Hino :IsaKd versus IsaPd: A multicenter propensity score matched retrospective analysis , 第86回日本血液学会学術集会, 京都, 2024.10.11-13(一般口演) |
| 1-5 | Tetsuya Hayashi, Kazuo Tanaka, Daiki Mukai, Yasuhiro Nakashima, Mitsutaka Nishimoto, Hiroshi Okamura, Teruhito Takakuwa, Masatomo Kuno, Yosuke Makuuchi, Kentaro Ido, Kazuki Sakatoku, Mirei Horiuchi, Mika Nakamae, Masayuki Hino, Hirohisa Nakamae :Fulminant delayed toxicity in the gastrointestinal tract after CAR-T cell therapy , 第86回日本血液学会学術集会, 京都, 2024.10.11-13(一般口演) |
| 1-6 | Yutaka Shimazu, Junya Kanda, Yoshiyuki Onda, Shinichi Fuchida, Kensuke Ohta, Yuji Shimura, Satoru Kosugi, Ryosuke Yamamura, Mitsuhiro Matsuda, Hitoshi Hanamoto, Yoko Adachi, Naoyuki Anzai, Masaaki Hotta, Kentaro Fukushima, Hideo Yagi, Satoshi Yoshihara, Yasuhiro Tanaka, Teruhito Takakuwa, Hirokazu Tanaka, Hirohiko Shibayama, Nobuhiko Uoshima, Naoki Hosen, Tomoki Ito, Chihiro Shimazaki, Itaru Matsumura, Junya Kuroda, Akifumi Takaori Kondo, Masayuki Hino :Predicting efficacy of isatuximab + pomalidomide for multiple myeloma by lymphocyte/monocyte ratio , 第86回日本血液学会学術集会, 京都, 2024.10.11-13(一般口演) |
| 1-7 | Masatomo Kuno, Hideo Koh, Yusuke Okayama, Yukako Yasui, Wataru Shibata, Tsubasa Koyama, Makoto Nishijima, Seidai Tanaka, Yuto Izuta, Daiki Mukai, Mai Kawazoe, Hidekatsu Yae, Nobuhiro Sogabe, Soichiro Nakako, Kumiyo Tazoe, Mirei Horiuchi, Kentaro Ido, Kazuki Sakatoku, Yosuke Makuuchi, Teruhito Takakuwa, Hiroshi Okamura, Mitsutaka Nishimoto, Yasuhiro Nakashima, Mika Nakamae, Hiroyuki Yasui, Hiroshi Kakeya, Masayuki Hino, Hirohisa Nakamae : Drug interactions between posaconazole and tacrolimus by route of administration, 第86回日本血液学会学術集会,京都, 2024.10.11-13(一般口演) |
| 1-8 | Yusuke Okayama, Hideo Koh, Masatomo Kuno, Yukako Yasui, Wataru Shibata, Tsubasa Koyama, Makoto Nishijima, Seidai Tanaka, Yuto Izuta, Daiki Mukai, Mai Kawazoe, Hidekatsu Yae, Nobuhiro Sogabe, Soichiro Nakako, Kumiyo Tazoe, Mirei Horiuchi, Kentaro Ido, Kazuki Sakatoku, Yosuke Makuuchi, Teruhito Takakuwa, Hiroshi Okamura, Mitsutaka Nishimoto, Yasuhiro Nakashima, Mika Nakamae, Hiroyuki Yasui, Hiroshi Kakeya, Masayuki Hino, Hirohisa Nakamae : High day 7 posaconazole concentration is a risk factor for hypokalemia, 第86回日本血液学会学術集会, 京都, 2024.10.11-13(一般口演) |
| 1-9 | Hirokazu Tanaka, Atsushi Shinagawa, Kohmei Kubo, Taizo Shimomura, Tatsuro Jo, Akihiko Gotoh, Shuichi Ota, Kensuke Usuki, Kosei Matsue, Miki Ando, Michihiro Uchiyama, Hiroaki Ohnishi, Yoshiaki Ogawa, Yoko Kubuki, Teruhito Takakuwa, Takuji Yamauchi, Kazuo Ito, Mitsufumi Nishio, Go Fujimoto, Akitsugu Takada, Patricia Martin-Regueira, Keita Kirito :Japan phase 1/2 study of fedratinib in JAK inhibitor pretreated/-untreated myelofibrosis (MF-003) 第86回日本血液学会学術集会, 京都, 2024.10.11-13(一般口演) |
| 1-10 | Minako Tsutsumi, Teruhito Takakuwa, Makoto Nishijima, Mirei Horiuchi, Yosuke Nakaya, Kazuki Sakatoku, Kentaro Ido, Yosuke Makuuchi, Masatomo Kuno, Hiroshi Okamura, Mitsutaka Nishimoto, Yasuhiro Nakashima, Mika Nakamae, Kaori Sakamoto, Chisato Ohe, Kenichi Kohashi, Masayuki Hino, Hirohisa Nakamae : Severe diarrhea as an immune-related adverse event of epcoritamab in two cases of refractory DLBCL, 第86回日本血液学会学術集会, 京都, 2024.10.11-13(一般口演) |
| 1-11 | Tomoki Ito, Teruhito Takakuwa, Masayuki Hino, Hirohisa Nakamae, Kazunori Murai, Yoko Kubuki, Kazuya Shimoda, Yuji Kumagai, Yukiya Yamamoto, Tadashi Matsuura :Phase I Safety Study of Anti-Transferrin Receptor 1 Antibody (PPMX-T003) in Patients with Polycythemia Vera and Erythrocythemia,66th ASH Annual Meeting, San Diego,2024.12.07-10(ポスター発表) |
| 1-12 | 安井友佳子、岡山裕介、久野雅智、康秀男、柴多渉、掛屋弘、安井裕之 :血液疾患患者におけるポサコナゾールの血中濃度に影響する遺伝子多型を含む因子解析,第34回日本医療薬学会年会,2024.11.02 |
| 1-13 | 岡山裕介:血液疾患患者におけるポサコナゾールの血中濃度に影響する遺伝子多型を含む因子解析,第34回日本医療薬学会年会, 千葉,2024.11.03(一般口演) |
2.学術論文
| 2-1 | Ichiro Shiomi, Yosuke Makuuchi, Ikue Noura, Shigeki Kakuno, Makoto Niki, Yuto Kaimi, Kentaro Ido, Kazuki Sakatoku, Masatomo Kuno, Teruhito Takakuwa, Hiroshi Okamura, Mitsutaka Nishimoto, Yasuhiro Nakashima, Mika Nakamae, Hiroshi Kakeya, Kenichi Kohashi, Masayuki Hino, Hirohisa Nakamae:Invasive fungal infection caused by Blastobotrys mokoenaii in an immunocompromised patient with acute myeloid leukemia: A case report,J Infect Chemother. 2024 Jun;30(6):557-561. ,(症例報告) |
| 2-2 | Masatomo Kuno, Hideo Koh, Kentaro Ido, Kazuki Sakatoku, Yosuke Makuuchi, Teruhito Takakuwa, Asao Hirose, Hiroshi Okamura, Mitsutaka Nishimoto, Yasuhiro Nakashima, Mika Nakamae, Masayuki Hino, Hirohisa Nakamae : Comparison of long-term outcomes after first HLA-mismatched unrelated donor transplantation with single unrelated cord blood transplantation using reduced-intensity or reduced-toxicity conditioning, Transpl Immunol. 2024 Feb:82:101988. ,(原著) |
| 2-3 | Yusuke Okayama, Naonori Harada, Yosuke Makuuchi, Masatomo Kuno, Teruhito Takakuwa, Hiroshi Okamura, Asao Hirose, Mika Nakamae, Mitsutaka Nishimoto, Yasuhiro Nakashima, Hideo Koh, Masayuki Hino, Hirohisa Nakamae : Pretransplant hepatomegaly is linked to relapse in patients with leukemia and myelodysplastic syndrome not in remission,Int J Hematol. 2024 Mar;119(3):316-326.,(原著) |
| 2-4 | Asao Hirose, Hideo Koh, Mika Nakamae, Yasuhiro Nakashima, Mitsutaka Nishimoto, Hiroshi Okamura, Yosuke Makuuchi, Masatomo Kuno, Teruhito Takakuwa, Kentaro Ido, Kazuki Sakatoku, Masayuki Hino, Hirohisa Nakamae: A comparison of long-term outcomes by donor type in the era of post-transplantation cyclophosphamide for aggressive adult T-cell leukemia/lymphoma, Bone Marrow Transplant. 2024 May;59(5):695-698.,(Letter) |
| 2-5 | Kumiyo Tazoe, Naonori Harada, Yosuke Makuuchi, Masatomo Kuno, Teruhito Takakuwa, Hiroshi Okamura, Asao Hirose, Mika Nakamae, Mitsutaka Nishimoto, Yasuhiro Nakashima, Hideo Koh, Masayuki Hino, Hirohisa Nakamae: Systemic inflammatory autoimmune disease before allogeneic hematopoietic stem cell transplantation is a risk factor for death in patients with myelodysplastic syndrome or chronic myelomonocytic leukemia, Ann Hematol. 2024 Jun;103(6):2059-2072.,(原著) |
| 2-6 | Kazuo Fukumoto, Ryu Watanabe, Minako Tsutsumi, Teruhito Takakuwa, Masafumi Miyamoto, Noriyuki Hayashi, Shinsuke Yamada, Yutaka Furumitsu, Masayuki Hino, Motomu Hashimoto: Lymphoproliferative disorder progressing after partial remission following immunosuppressive drugs withdrawal in a patient with rheumatoid arthritis, Mod Rheumatol Case Rep. 2024 Jul 8;8(2):243-248. ,(症例報告) |
| 2-7 | Makoto Moriguchi, Kentaro Ido, Hiroshi Okamura, Mika Nakamae, Kazuki Sakatoku, Yosuke Makuuchi, Masatomo Kuno, Teruhito Takakuwa, Asao Hirose, Mitsutaka Nishimoto, Yasuhiro Nakashima, Hideo Koh, Masayuki Hino, Hirohisa Nakamae: Impacts of Posttransplant Cyclophosphamide Dose on Graft-versus-leukemia Effects via HLA-B Leader in HLA-haploidentical Peripheral Blood Stem Cell Transplantation, Acta Haematol. 2024;147(6):661-670,(原著) |
| 2-8 | Naokazu Nakamura, Nobuyoshi Arima, Teruhito Takakuwa, Satoshi Yoshioka, Kazunori Imada, Kentaro Fukushima, Masaaki Hotta, Shin-Ichi Fuchida, Junya Kanda, Nobuhiko Uoshima, Yuji Shimura, Hirokazu Tanaka, Kensuke Ohta, Satoru Kosugi, Hideo Yagi, Satoshi Yoshihara, Ryosuke Yamamura, Yoko Adachi, Hitoshi Hanamoto, Hirohiko Shibayama, Naoki Hosen, Tomoki Ito, Chihiro Shimazaki, Akifumi Takaori-Kondo, Junya Kuroda, Itaru Matsumura, Masayuki Hino: Efficacy of elotuzumab for multiple myeloma deteriorates after daratumumab: a multicenter retrospective study,Ann Hematol. 2024 Dec;103(12):5681-5690.,(原著) |
| 2-9 | Kazuya Takemura, Mika Nakamae, Hiroshi Okamura, Kazuki Sakatoku, Kentaro Ido, Yosuke Makuuchi, Masatomo Kuno, Teruhito Takakuwa, Asao Hirose, Mitsutaka Nishimoto, Yasuhiro Nakashima, Hideo Koh, Koji Igarashi, Hiroshi Kubota, Masayuki Hino, Hirohisa Nakamae: Autotaxin is a potential predictive marker for the development of veno-occlusive disease/sinusoidal obstruction syndrome after allogeneic hematopoietic cell transplantation, Ann Hematol. 2024 May;103(5):1705-1715,(原著) |
| 2-10 | Yosuke Makuuchi, Hiroshi Okamura, Yukari Umemoto, Akinori Nishikawa, Rie Tanaka, Akari Sato, Kazuki Sakatoku, Kentaro Ido, Mirei Horiuchi, Masatomo Kuno, Teruhito Takakuwa, Mitsutaka Nishimoto, Yasuhiro Nakashima, Mika Nakamae, Shingo Yano, Masayuki Hino, Hirohisa Nakamae: Usefulness of web-based application for health surveys before and after peripheral blood stem cell harvest from healthy donors, Rinsho Ketsueki. 2024;65(5):321-329.,(原著) |
| 2-11 | Soichiro Nakako, Hideo Koh, Nobuhiro Sogabe, Masatomo Kuno, Yosuke Makuuchi, Teruhito Takakuwa, Hiroshi Okamura, Mitsutaka Nishimoto, Yasuhiro Nakashima, Masayuki Hino, Hirohisa Nakamae: Successful treatment with mesenchymal stem cells for steroid-refractory late-onset idiopathic pneumonia syndrome following allogeneic hematopoietic cell transplantation, Transpl Immunol. 2024 Oct:86:102107.,(症例報告) |
| 2-12 | Joji Nagasaki, Mitsutaka Nishimoto, Hideo Koh, Hiroshi Okamura, Mika Nakamae, Kazuki Sakatoku, Kentaro Ido, Masatomo Kuno, Yosuke Makuuchi, Teruhito Takakuwa, Yasuhiro Nakashima, Masayuki Hino, Hirohisa Nakamae: T cells with high BCL-2 expression induced by venetoclax impact anti-leukemic immunity “graft-versus-leukemia effects”,Blood Cancer J. 2024;14(1):79.,(原著) |
| 2-13 | Yutaka Shimazu, Junya Kanda, Yoshiyuki Onda, Shin-Ichi Fuchida, Kensuke Ohta, Yuji Shimura, Satoru Kosugi, Ryosuke Yamamura, Mitsuhiro Matsuda, Hitoshi Hanamoto, Yoko Adachi, Naoyuki Anzai, Masaaki Hotta, Kentaro Fukushima, Hideo Yagi, Satoshi Yoshihara, Yasuhiro Tanaka, Teruhito Takakuwa, Hirokazu Tanaka, Hirohiko Shibayama, Nobuhiko Uoshima, Naoki Hosen, Tomoki Ito, Chihiro Shimazaki, Itaru Matsumura, Junya Kuroda, Akifumi Takaori-Kondo, Masayuki Hino: The lymphocyte/monocyte ratio predicts the efficacy of isatuximab plus pomalidomide in multiple myeloma patients, Cancer Immunol Immunother. 2024;73(7):135.,(原著) |
| 2-14 | Soichiro Nakako, Hiroshi Okamura, Isao Yokota, Yukari Umemoto, Mirei Horiuchi, Kazuki Sakatoku, Kentaro Ido, Yosuke Makuuchi, Masatomo Kuno, Teruhito Takakuwa, Mitsutaka Nishimoto, Asao Hirose, Mika Nakamae, Yasuhiro Nakashima, Hideo Koh, Masayuki Hino, Hirohisa Nakamae: Dynamic Relapse Prediction by Peripheral Blood WT1mRNA after Allogeneic Hematopoietic Cell Transplantation for Myeloid Neoplasms, Transplant Cell Ther. 2024 Nov;30(11):1088.e1-1088.e12.,(原著) |
| 2-15 | Yutaka Shimazu, Junya Kanda, Teruhito Takakuwa, Yoshiyuki Onda, Kentaro Fukushima, Masaaki Hotta, Shin-Ichi Fuchida, Nobuhiko Uoshima, Yuji Shimura, Hirokazu Tanaka, Kensuke Ohta, Hirohiko Shibayama, Satoru Kosugi, Hideo Yagi, Satoshi Yoshihara, Naoki Hosen, Tomoki Ito, Chihiro Shimazaki, Itaru Matsumura, Junya Kuroda, Akifumi Takaori-Kondo, Masayuki Hino: The impact of renal function on initial therapy in transplant-ineligible multiple myeloma patients, Ann Hematol. 2024 Dec;103(12):5639-5649.,(原著) |
| 2-16 | Tetsuya Hayashi, Yasuhiro Nakashima, Shinichi Takeda, Mitsutaka Nishimoto, Hiroshi Okamura, Teruhito Takakuwa, Masatomo Kuno, Yosuke Makuuchi, Kentaro Ido, Kazuki Sakatoku, Mirei Horiuchi, Hideo Koh, Mika Nakamae, Masayuki Hino, Hirohisa Nakamae: Posttransplantation cyclophosphamide mediates effective reconstitution of memory B cells after allogeneic hematopoietic cell transplantation, Eur J Haematol. 2024;113(5):651-663.,(原著) |
| 2-17 | Kazutaka Sunami, Tomoaki Fujisaki, Toshinari Funaki, Michiko Ichii, Shigeki Ito, Morio Matsumoto, Koh-Ichi Oshima, Kazuhito Suzuki, Teruhito Takakuwa: Practical guidance on the clinical management of ocular adverse events associated with belantamab mafodotin in patients with relapsed/refractory multiple myeloma: Recommendations from a , Jpn J Clin Oncol. 2025 Oct 6:hyaf148,(review) |
| 2-18 | 髙桑輝人、岡山裕介、太田健介、中前博久、日野雅之、山中英治: 「血液疾患（造血器腫瘍）連携クリニカルパス」を活用した拠点病院と地域医療との橋渡し,日本クリニカルパス学会誌. 2025;27(4):492-497,(特集) |
| 2-19 | Yusuke Okayama, Teruhito Takakuwa, Yuji Shimura, Kazunori Imada, Satoru Kosugi, Masaaki Hotta, Shin-Ichi Fuchida, Hirokazu Tanaka, Nobuhiko Uoshima, Satoshi Yoshihara, Junya Kanda, Hirohiko Shibayama, Kentaro Fukushima, Kensuke Ohta, Hideo Yagi, Tomoki Ito, Chihiro Shimazaki, Itaru Matsumura, Akifumi Takaori-Kondo, Naoki Hosen, Masayuki Hino, Junya Kuroda: Insights into very elderly multiple myeloma treatment from Kansai Myeloma Forum,Hematology. 2025 Dec;30(1):2496545,(原著) |